Skip to main content
OpenTrials
Completed

NCT Number: NCT03784742

Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Function

Diseases of the heart and blood vessels, including raised blood pressure, are one of the leading causes of death worldwide. Higher intakes of dietary nitrate, found abundantly in root vegetables such as beetroot, have been shown to have health benefits including lowering blood pressure and improving the elasticity of blood vessels. Bacteria which reside in the mouth and those in the gastrointestinal tract play an important role in converting dietary nitrate to nitrite and nitric oxide (a chemical which promotes the relaxation of blood vessels). In particular, removal of oral bacteria by using antiseptic mouthwash is accompanied by an increase in blood pressure in subjects with normal blood pressure, even after consuming nitrate-rich foods. To date, very little is known about the role of these oral bacteria in the control of blood pressure, and if there are any differences in bacterial composition between individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading

Reading, Berkshire, RG6 6AP, United Kingdom

About this study

Interested volunteers will be provided with an outline of the study and asked to complete a medical and lifestyle questionnaire (in person, by email or over the phone). Potentially suitable participants will be identified and asked to attend a screening session after a 12 h overnight fast (not eating during this time and only drinking water) during which the study will be explained in more detail before a consent form is signed. Anthropometric measurements will then be taken including weight, height and blood pressure. A 9 ml blood sample will also be collected on site at the Department of Food and Nutritional Sciences (Hugh Sinclair Unit of Human Nutrition). Subjects who meet the initial inclusion criteria will be invited to a further screening session during which time a dentist will check for dental diseases (e.g. current dental cavities or periodontal infection) and saliva flow rate. Volunteers without periodontal disease and with normal saliva flow will then be invited to participate in the study.

Eligible subjects will then be randomised to one of two treatments: i) up to 70 ml (the amount given will be equivalent to 3.7 mg/kg body weight) beetroot juice (James White Drinks Limited, UK) or ii) a matched volume of placebo beetroot juice (control, James White Drinks Limited, UK) to be consumed daily for 8 weeks. As drinking water is a major source of dietary nitrate, subjects will be provided with a water filter to reduce the nitrate level in their tap water for drinking and cooking during the study period. There will be a wash out period of 4 weeks between the intervention juices. In total, volunteers will be involved in the study for 20 weeks (five months).

On the day before each baseline study visit (weeks 0 and 12), volunteers will be required to fast overnight after having a low nitrate evening meal and only drinking low nitrate mineral water (Buxton mineral water), which will be provided to them, during this time. They will refrain from strenuous exercise and alcohol. On the morning of the study visit, the volunteers will be asked not to brush their teeth before they come to the clinical unit for their study visit.

When they arrive in the fasted state, the participants will be asked to provide a spot urine sample and a stool sample. Body weight and composition will be measured using the Tanita weighing scale, saliva sample and an oral bacteria sample will be collected by swabbing the tongue with a cotton swab. Volunteers will be asked to lie down for 20 minutes prior to the measurement of blood pressure and pulse wave analysis (PWA) using the Mobil-O-Graph device followed by the assessment of microvascular reactivity using Laser Doppler Imaging with iontophoresis. A blood sample of 20 ml (equivalent to just over 1 tablespoon) will then be taken before a light breakfast is provided. Volunteers will then be given a toothbrush and toothpaste to brush their teeth and asked to complete an online food frequency questionnaire (EatwellUK).

During the four-week wash-out period between interventions, participants will be instructed to avoid any beetroot juice drinks and maintain their usual dietary and lifestyle habits.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male and female;

  • A signed consent form;
  • Blood pressure <140/90 mm Hg;
  • BMI range 18.5 - 39.9 kg/m2;
  • Age 18-64 years;
  • Non-smoking;
  • Not taking blood pressure lowering medication or using medications known to influence vascular function such as a glyceryl trinitrate (GTN) spray;
  • No recent (within 3 months) or current use of antibiotics.

Exclusion criteria

are:

Diagnosed with a chronic illness;

  • Anaemia defined as a haemoglobin < 115 g/l for women and <130 g/l for men;
  • Individuals with food allergies or allergies to medicated mouthwash or ingredients in the oral products;
  • Requirements to take long-term medication active on the oral cavity including prebiotics and probiotics or have taken antibiotics within the last 3 months;
  • Gingivitis diagnosis, or periodontal disease or chronic oral complaints or existing oral pathology.
  • Less than four natural (enamel) buccal surfaces of upper molars available;
  • Presence of fixed or removable oral appliances (e.g., dentures, orthodontic wires); xerostomia (a persistent dry mouth) diagnosis;
  • Current smoker;
  • Already participating in a dietary intervention study or clinical trial;
  • Excessive alcohol consumption (> 14 units/wk);
  • Females who are pregnant or lactating;
  • Individuals not willing to give up using mouthwash or change their dental hygiene routine. Regular consumption or use of xylitol-based products such as toothpaste and chewing gum.

Treatment and study plan

Nitrate rich beetroot juice

Other

James White Drinks Limited beetroot juice (0.4-0.45 g nitrate/70 ml drink).

Placebo beetroot juice

Other

James White Drinks Limited Placebo beetroot juice (0 nitrate/70 ml drink).

Primary outcomes

  1. Change in blood pressure measure

    Time frame: Before and after each 8 week intervention

    Systolic blood pressure, diastolic blood pressure and pulse pressure

  2. Change in oral bacteria composition

    Time frame: Before and after each 8 week intervention

    Oral bacteria composition determined using next generation sequencing.

Secondary outcomes

  1. Change in vascular reactivity

    Time frame: Before and after each 8 week intervention

    Laser Doppler Imaging with iontophoresis.

  2. Change in Nox concentrations in serum, urine and saliva

    Time frame: Before and after each 8 week intervention

    Nitrate and nitrite concentrations will be determined using high performance liquid chromatography in plasma, urine and saliva. Nitric oxide will be calculated as the sum of nitrate and nitrite concentrations.

    Creatinine will be measured in the urine samples to normalise the nitrate and nitrite concentrations in urine for hydration status.

  3. Change in gut bacteria composition

    Time frame: Before and after each 8 week intervention

    Stool sample will be analysed to determine composition using next generation sequencing will be used to find the differences between treatments.

  4. Change in fasting lipid profile

    Time frame: Before and after each 8 week intervention

    Total cholesterol, HDL-C, and triacylglycerol will be measured using a clinical chemistry analyser. LDL-C will be calculated using the Friedewald formula.

  5. Change in C-reactive protein

    Time frame: Before and after each 8 week intervention

    C-reactive protein will be measured using a clinical chemistry analyser

  6. Change in endothelial function

    Time frame: Before and after each 8 week intervention

    Pulse wave analysis will be measured using Mobil-O-Graph

  7. Change in body weight

    Time frame: Before and after each 8 week intervention

    Body weight will be measured using a Tanita scale

  8. Height measurement

    Time frame: Before the intervention

    Height will be measured using a stadiometer

  9. Change in body mass index

    Time frame: Before and after each 8 week intervention

    Body mass index will be calculated from the body weight and height measurement

  10. Change in insulin

    Time frame: Before and after each 8 week intervention

    Insulin levels will be measured by ELISA

  11. Change in glucose

    Time frame: Before and after each 8 week intervention

    Glucose levels will be measured using a clinical chemistry analyser

  12. Change in insulin sensitivity

    Time frame: Before and after each 8 week intervention

    Glucose and insulin measurements will be used to calculate the homeostatic model assessment of insulin resistance (HOMA-IR)

Sponsors and collaborators

Lead sponsor

University of Reading

Other

Collaborators

  • Saudi Cultural Bureau

Registry information

Official study title

Investigation of the Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Functio

Acronym: REBOC2

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Dec 24, 2018
Registry last updated
Apr 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.